
To provide your tissues with energy, your cells must convert glucose from the food you eat into cellular energy, known as ATP. This process requires a coordinated series of enzymatic reactions, and a defect in one or more of these enzymes can severely compromise cell function. For example, pyruvate dehydrogenase, or PDH, deficiency impairs glucose metabolism in sufferers and can lead to toxic blood acidity levels and neurological damage. However, a ketogenic diet for individuals with PDH deficiency may improve their prognosis, even in those who have concurrent diabetes.
Role of Pyruvate Dehydrogenase
Converting glucose into ATP requires glycolysis, which converts glucose into pyruvate in a series of enzymatic reactions. A transporter protein moves the pyruvate into the mitochondria, where the PDH enzyme converts it into another molecule known as acetyl coenzyme A. Provided you have sufficient oxygen available, the mitochondria converts the acetyl coenzyme A into ATP using a series of enzymatic reactions. However, insufficient oxygen or PDH deficiency will lead to a buildup of pyruvate outside the mitochondria, which is converted to lactate. Excess lactate and lactic acid production increases the acidity of your blood and may lead to metabolic acidosis.
Pyruvate Dehydrogenase Deficiency
PDH deficiency is a rare inherited condition usually evident at infancy or in early childhood. The majority of cases are caused by a mutation in the E1 alpha gene, which is responsible for making a large part of the PDH enzyme. However, mutations in other genes and cofactors responsible for PDH function can also cause PDH deficiency. Since glucose is the primary source of fuel for the nervous system, infants with PDH deficiency often experience developmental delay, mental retardation and seizures. Additionally, the pyruvate buildup contributes to excess lactate production and sometimes high blood ammonia levels.
Pyruvate Dehydrogenase Deficiency Treatment
Treatment of PDH deficiency often does not influence disease progression, but it may reduce the occurrence of life-threatening symptoms such as breathing difficulties and seizures. The response to treatments also depends on the severity of the condition and the origin of the deficiency. Generally, treatments aim to stimulate PDH enzyme activity, provide enzyme cofactors such as thiamine, and reduce acidosis. A 2006 article published in “Journal of Child Neurology” showed that a 4-year-old girl with PDH deficiency increased developmental progress, overall activity level, and metabolic health after consuming a ketogenic diet for 28 days. This special diet is high in fat to provide an alternate source of acetyl coenzyme A and low in carbohydrate diet to limit pyruvate production from glucose.
Ketogenic Diets and Diabetes
Diabetes is a metabolic disorder characterized by insufficient glucose uptake into cells, which can lead to excessive ketone body production and life-threatening ketoacidosis if left untreated. Although ketogenic diets improve symptoms of PDH deficiency, scientists previously discouraged their use in diabetic individuals because they may increase the risk of ketoacidosis. However, the 4-year-old girl mentioned previously was also diabetic, and her body’s glucose-handling ability improved after consuming the ketogenic diet. Type 2 diabetics also improved glycemic control and were able to reduce their diabetes medication dosages in a 2008 study published in “Nutrition and Metabolism.”










